Logo

    Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

    enSeptember 01, 2023
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    In this episode, Contributing Editor Kate Markey, MBBS, PhD, talks with Shernan Holtan, MD, one of the authors of a paper published recently in The New England Journal of Medicine: “Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis.”

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    Recent Episodes from The Hematologist

    Toward Equity in Access for ALL

    Toward Equity in Access for ALL

    In this episode, Contributing Editor Lori Muffly, MD, an associate professor of medicine specializing in blood and marrow transplantation and cellular therapies at Stanford University in California, talks with Roberta Demichelis, MD, an assistant professor in the department of hematology and oncology at the Salvador Zubirán National Institute of Health Sciences and Nutrición in Mexico City. They discuss access to care for patients with acute lymphoblastic leukemia in low- and middle-income countries, especially among Hispanic populations. 

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enJanuary 30, 2024

    The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

    The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

    In this episode, Contributing Editor Sarah Tasian, MD, associate professor at the University of Pennsylvania School of Medicine and chief of the hematologic malignancies program at the Children’s Hospital of Philadelphia, talks with Rob Pieters, MD, the chief medical officer at the Princess Maxima Center for Pediatric Oncology and professor of pediatric oncology at the University of Utrecht, both in Utrecht, Netherlands. Dr. Pieters is one of the authors of a paper published recently in The New England Journal of Medicine: “Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.”

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enNovember 29, 2023

    Editors-in-Chief of Two New ASH Journals Share Their Visions

    Editors-in-Chief of Two New ASH Journals Share Their Visions

    In this episode, Dr. Shaji Kumar, editor-in-chief of The Hematologist, has a conversation with Drs. Jonathan Licht and Keith McCrae, the editors-in-chief, respectively, of ASH's two new journals Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis.

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enOctober 20, 2023

    ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All

    ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All

    In this episode, Dr. Satiro De Oliveira talks about his own experience with the mentorship program within ASH’s Minority Recruitment Initiative and its impact on trainees coming from underrepresented groups. Dr. De Oliveira is an associate professor in the Division of Pediatric Hematology Oncology at UCLA.

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enSeptember 18, 2023

    Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

    Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

    In this episode, Contributing Editor Kate Markey, MBBS, PhD, talks with Shernan Holtan, MD, one of the authors of a paper published recently in The New England Journal of Medicine: “Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis.”

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enSeptember 01, 2023

    Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal

    Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal

    In this episode, Contributing Editor Dr. Robert Hasserjian has a conversation with Dr. Siddhartha Jaiswal about a recent paper Dr. Jaiswal co-authored: “Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.” 

     

    Dr. Hasserjian is a professor of pathology at Harvard Medical School. He is also the director of the Hematopathology Fellowship Program at Massachusetts General Hospital. Dr. Jaiswal is an assistant professor of pathology at Stanford University School of Medicine.

     

    Dr. Hasserjian wrote about Dr. Jaiswal’s paper in his recent Diffusion article in The Hematologist. You can access his Diffusion article online at: https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V20.4.202344/496652/Genetic-Background-Influences-the-Growth-of-CHIP

     
    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enJuly 07, 2023

    Drawing New Blood Into Hematology

    Drawing New Blood Into Hematology

    In this episode, Drs. Robert Stern and Ronak Mistry talk about their own professional journeys as hematologists, why they love what they do, the medical education for hematologists, and recruitment efforts to bring more students into the field.

    Dr. Stern is the associate program director with the Dana-Farber Massachusetts General Brigham Fellowship in Hematology and Oncology in Boston. 

    Dr. Mistry is a clinical fellow in the division of hematology and oncology at Vanderbilt University Medical Center in Nashville.

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enJune 16, 2023

    Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action

    Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action

    In this episode, Contributing Editor Dr. Michael Scott is joined by Dr. Sumedha Arya for a conversation with Dr. Cindy de Jong. They discuss a study covered by Drs. Scott and Arya in their recent Diffusion article titled “Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action.” Dr. de Jong performed analysis for the study and served as one of the lead authors of the paper published in Blood. To access the Diffusion article online, please click here. 

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enMay 18, 2023

    ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology

    ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology

    In this installment, Dr. Nicole Gormley and Dr. Grzegorz Nowakowski discuss a collaboration between ASH and the FDA that led to a successful workshop on regulatory science in hematology, an event they co-chaired and one that will return Oct. 10–11 at ASH headquarters in Washington, D.C. Dr. Gormley, a hematologist with the FDA, is the Division Director for the Division of Hematologic Malignancies 2 and the Acting Associate Director for Oncology Endpoint Development within the Oncology Center of Excellence. Dr. Nowakowski is a hematologist at the Mayo Clinic Rochester where he serves as the Deputy Cancer Center Director for Clinical Research. Dr. Nowakowski also serves as Chair of the ASH Subcommittee on Clinical Trials.

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enApril 21, 2023

    The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil

    The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil

    In this installment, Contributing Editor Dr. Loretta J. Nastoupil has a conversation with Dr. Michael Dickinson. They discuss the New England Journal of Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma.” In the article, Dr. Nastoupil discusses a study that looks at a promising therapy for the management of diffuse large B-cell lymphoma. Read more 

    Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

    The Hematologist
    enApril 04, 2023
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io